Thanks for all who've followed my initial post on this matter. I've been looking through The Allens handbook on
takeovers in Australia and found "The initial approach to the target is usually conducted verbally, and followed by a written
confidential, non-binding and indicative proposal. The target generally has no obligation to announce such a proposal - unless it ceases to become confidential – but could decide to do so for strategic reasons."
Here, as the Fin Review suggests, the Board has made a strategic decision to announce. For me that suggests they are willing to sell to Albemarle, and Goyder must be in the mix in the negotiations so he's dictating a price. May he keep up the dictating!
- Forums
- ASX - By Stock
- LTR
- Ann: Liontown rejects Indicative Proposal from Albemarle
Ann: Liontown rejects Indicative Proposal from Albemarle, page-287
-
-
- There are more pages in this discussion • 695 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.418B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online